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Background: A major limitation in the application of assisted reproductive technologies in sheep arises from the
inability to easily traverse the uterine cervix. The cervix of the non-pregnant ewe is a narrow and rigid structure,
with 5–7 spiral folds and crypts that block its lumen. The first two folds closest to the vagina appear to be the
greatest obstacle for the instrument insertion into the sheep cervix. Therefore, the dilation of the distal part of the
cervix could provide the conformational change necessary to perform non-invasive transcervical procedures. The
present study set out to assess the efficacy of Cervidil®, a patented dinoprostone (PgE2)-containing vaginal insert
with a controlled-release mechanism, to safely induce sufficient cervical dilation for the purpose of transcervical
embryo transfer (TCET) in cyclic ewes.
Methods: The transfer of frozen-thawed ovine embryos was attempted in 22 cross-bred Rideau Arcott x Polled
Dorset ewes, with or without the pre-treatment with Cervidil® for 12 or 24 h prior to TCET.
Results: Cervical penetration rate was significantly improved after Cervidil® pre-treatment, with 55% (6/11) of
treated versus 9% (1/11) of control animals successfully penetrated (χ2-test, p < 0.05). Within the treated ewes that
were penetrated, 67% (4/6) had been exposed to Cervidil(R) for 24 h and 33% (2/6) had had a 12-h exposure
(p > 0.05). Variations in the age, weight, genotype, parity, lifetime lamb production (LLP) and post-partum interval
(PPI) between penetrated and non-penetrated ewes were not significant (p > 0.05). The time taken to traverse the
uterine cervix was negatively correlated (p < 0.05) with the age, parity, LLP and PPI. Progesterone assays and
ultrasonographic examinations performed 25 days after ET confirmed pregnancy in 2 of 7 penetrated ewes, but no
fetuses were detected ultrasonographically 55 days post-TCET.
Conclusions: The present results indicate a significant benefit of using Cervidil® for inducing cervical dilation during
the mid-luteal phase in ewes but the reason(s) for impaired fertility after the transfer of frozen-thawed ovine
embryos remains to be elucidated.
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The ability to gain from the benefits of embryo transfer
(ET) in commercial settings is predominantly due to the
ease with which these procedures can be executed. Sur-
gical approaches are not necessary to perform ET in
most species of veterinary interest but rather the trans-
cervical route is used. The ovine cervix, however, is a
narrow and rigid structure with a complex, tortuous ar-
rangement that precludes easy transcervical passage and
intrauterine deposition of harvested embryos in recipient* Correspondence: pmbart@uoguelph.ca
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article, unless otherwise stated.ewes using conventional ET catheters [1,2]. The main
method used to circumnavigate this anatomical barrier
involves surgical intervention; intrauterine ET in sheep
is usually performed via mid-ventral laparoscopy [3,4].
Although considered moderately invasive, this procedure
causes undue stress to animals, is time consuming,
costly, labor intensive, and requires specialized equip-
ment and qualified personnel. The repeated use of this
technique is also a concern for animal welfare. As a re-
sult, the use of laparoscopic ET is not widespread in the
sheep industry and is limited to small flocks of usually
rare, expensive, heritage breeds. The cost to benefit ratio
of surgical transfers is not favorable especially if theMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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reliable transcervical method of ET would be a valuable
asset to the sheep breeders. Wulster-Radcliffe et al. [5]
were able to achieve cervical penetration and intrauter-
ine embryo deposition in ewes. It was found that 53.5%
of embryos were retained at day 12 of pregnancy. Al-
though promising, these results were never repeated and
the development of the embryos past day 12 in utero
was not assessed.
Several modified catheters have been developed to
traverse cervical canal in sheep but the penetration rates
remain inconsistent and unpredictable [1]. Furthermore,
cervical trauma and local inflammation caused by re-
peated attempts to pass a rigid catheter through a highly
constricted cervix may have a negative impact on the en-
suing pregnancy and lambing rates [1]. A plausible solu-
tion would be to devise a means of dilating the ovine
cervix prior to manipulation to enlarge the cervical
lumen and thus enable the passage of ET instruments;
this would greatly decrease potential cervical injury and
its associated detrimental effects. Cervical dilation could
also increase the ease of transcervical ET making it less
dependent on operators’ skills and decreasing the
amount of time taken to perform the procedure. Dilation
of merely the first two caudal folds of the cervix, which
are the most constricted and misaligned, would be suffi-
cient to significantly facilitate transcervical instrument
passage [1].
An ideal pharmacological agent to induce cervical dila-
tion for the purpose of ET in ewes must be designed for
easy delivery and cause minimal discomfort to the ani-
mal [1]. Such an agent should not yield adverse residual
effects, neither maternal nor embryonic. In particular, it
should not induce uterine atony or hyperstimulation as
both of these conditions could interfere with the ability
of transferred embryos to successfully implant in the
endometrial layer. Cervidil® is a vaginal insert containing
synthetic analog of prostaglandin E2 (PgE2). It has been
established as a safe agent to induce cervical dilation in
periparturient women. Cervidil® releases PgE2 at a con-
stant rate to sustain physiological concentrations of the
prostaglandin, similar to those observed at early stages
of labor, and promoting cervical ripening without strong
concomitant effects on uterine contractility. We pro-
posed that the application of Cervidil® to cyclic sheep
may facilitate transcervical embryo deposition.
Hence, the present study was undertaken to assess the
utility of Cervidil® as an inducer of cervical dilation for
transcervical ET in ewes. The emphasis was on the dila-
tory effects of Cervidil® inserts and so the embryos from
only one source (frozen-thawed ovine embryos) were
used and no comparisons between fresh or frozen/
in vitro- or in vivo-produced embryos were attempted
in the present trial.Methods
Experimental animals
The present experiment utilized clinically healthy, sexu-
ally mature Rideau Arcott x Polled Dorset ewes with no
previous transcervical or laparoscopic artificial insemin-
ation or ET attempts, superovulatory treatments or re-
productive tract surgeries. Animals were housed in the
Ponsonby Sheep Research Station near Fergus, ON,
Canada (latitude: 43°42′N, longitude: 80°22′W). The
ewes were fed a maintenance diet of hay, and had ad
libitum access to fresh water and cobalt-iodized salt
licks. Preliminary statistical analyses revealed no signifi-
cant differences in the mean age, weight, breed, parity,
lifetime lamb production and post-partum interval
across all treatment and control groups of ewes in this
study (Table 1). All experimental procedures executed
were in compliance with the guidelines of the Canadian
Council on Animal Care and had been approved by the
local Animal Care Committee in Guelph, ON, Canada.
Superovulation and embryo recovery/freezing
In December, a total of 16 ewes were superovulated
using a standard superovulatory protocol [6]. Prior
to embryo collections, each ewe was anaesthetized
with 0.2 mg/kg b.w. of xylazine i.m. (Rompun®; Bayer
Animal Health, Etobicoke, ON, Canada) followed by
5 mg/kg b.w. of ketamine (Vetalar®; Bioniche Animal
Health Canada Inc., Belleville, ON, Canada), adminis-
tered i.v. ~10 min later. The uterine horns were exterior-
ized through a ventral midline incision 10 cm cranial to
the udder. A stab incision at the base of the uterine horn
close to the uterine bifurcation allowed for the insertion
of a Foley catheter, which was then inflated with air until
the tissue in contact with the ballooned area was taut.
An open-ended 1/5 14-cm tom-cat catheter was intro-
duced through a small puncture made at the utero-tubal
junction in order to inject 50 ml of flushing medium
(phosphate buffered saline + 1% bovine serum albumin +
penicillin + streptomycin) into the uterine horn. This
fluid was forced through the small opening in the Foley
catheter at the base of the uterine horn and then col-
lected into a sterile container; the process was repeated
for the second uterine horn. An experienced technician
immediately recovered from the collected fluid all em-
bryos that had developed to the blastocyst or morula
stage, using a stereomicroscope at 40X image magnifica-
tions. The morphological quality of the embryos was
assessed according to the embryo evaluation system
originally developed by Lindner and Wright for the bo-
vine species [7]; embryos were classified as excellent,
good, fair or poor (Grades 1–4). Following the evalu-
ation, a total of 84 transferable quality embryos (excel-
lent to fair), including 56 blastocysts and 28 morulae,
were placed in Dulbecco-modified phosphate buffered
Table 1 The ewe-related characteristics for all treatment and control groups of cyclic Rideau Arcott x Polled Dorset
ewes used in the transcervical embryo transfer (TCET) trial
Variable/Group Treatment Control
12-h (n = 5) 24-h (n = 6) 12-h (n = 6) 24-h (n = 5)
Age (days) 1392 ± 171 (812 to 2121) 1686 ± 132 (1307 to 2066) 1293 ± 176 (958 to 2067) 1340 ± 65 (1241 to 1573)
Weight (kg) 79.0 ± 3.1 (71 to 80) 81.6 ± 3.3 (71 to 90) 78.4 ± 6.7 (52 to 102) 82.2 ± 4.2 (70 to 95)
Breed (% Rideau Arcott) 75.0 ± 7.2 (62.5 to 100) 50.0 ± 6.2 (31.3 to 68.8) 58.3 ± 8.5 (25 to 81.3) 62.5 ± 5.6 (43 to 75)
Parity 2.2 ± 0.5 (1 to 4) 3.0 ± 0.4 (2 to 4) 1.8 ± 0.5 (1 to 4) 1.6 ± 0.4 (1 to 3)
Lifetime lamb production (lambs/ewe) 4.7 ± 1.1 (2 to 9) 6.2 ± 1.0 (3 to 10) 3.7 ± 1.3 (1 to 9) 3.2 ± 1.1 (1 to 7)
Post-partum interval (days) 226 ± 1 (226 to 229) 295 ± 36 (227 to 451) 316 ± 45 (225 to 454) 399 ± 151 (226 to 1001)
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taining 10% cell culture grade glycerol, 0.4% bovine
serum albumin and 0.1 M sucrose (ViGro® Freeze Plus;
Bioniche Animal Health Canada Inc., Belleville, ON,
Canada). The embryos were grouped in pairs or triplets of
blastocysts/morulae, packaged with media into 0.25-cc
straws, and subsequently frozen using the FTS Systems
Bio-Cool™ Controlled Rate Freezer (FTS Systems, Stone
Ridge, NY, USA). The freezing protocol was as follows:
starting temperature: −7°C for 10 min; freezing rate:
0.3°C/min; holding temperature: −35°C for 10 min; em-
bryos plunged into liquid nitrogen.
Cervidil®
The active ingredient in Cervidil® vaginal inserts (Ferring
Pharmaceuticals Inc., North York, ON, Canada) is a
synthetic analogue of prostaglandin E2 (PgE2), pharma-
cologically known as dinoprostone and chemically as
11α-15S-dihydroxy-9-oxo-prosta-5Z,13E-dien-1-oic acid
(molecular formula: C20H32O5). It consists of a flat,
thin, semi-opaque, rectangular-shaped pessary measur-
ing 29 mm × 9.5 mm and 0.8 mm in thickness, con-
tained within a slim, polyester knitted pouch with an
attached wide cord allowing convenient retrieval of
the product from the vaginal canal (Figure 1A). The pes-
sary is comprised of 241 mg of a hexanetriol/macrogol
8000/isocyanate cross-linked hydrogel copolymer matrix
with 10 mg of dinoprostone dispersed within it. This
specific configuration allows for the slow release of a
relatively constant dose of ~0.3 mg of dinoprostone per
hour. Once the insert is placed in a moist environment,
it will absorb water, swell slightly and begin releasing
dinoprostone. All the components of the insert are non-
toxic and have been well tolerated in placebo-controlled
trials [8-10] and clinical settings [11].
Considering that the Cervidil® insert is designed for
use in women remaining in a recumbent supine pos-
ition, the administration of the insert had to be modified
to better suit its use in ewes that are ambulatory during
the entire treatment period. Small rectangular blocks of
hypoallergenic spongy foam measuring 5 cm × 2.5 cm ×2.5 cm were each attached to a single, flat 12-cm long
knitted fabric cord, and the sponge portion was sealed
with a close-fitting, thin layer of non-toxic, malleable,
transparent polyethylene resin (Figure 1B) to prevent the
absorption of dinoprostone by the sponge. These manu-
factured “plugs” were used to prevent the Cervidil® in-
serts from being lost prematurely by positioning the
sponges caudally to the Cervidil® insert inside the vagina,
limiting the movement of the Cervidil® insert within
the vaginal canal. The sponges were also used as placebo




Twenty-two ewes were fitted with controlled internal
drug releasing (CIDR) devices (EAZI-BREED™ CIDR®
Sheep Insert; Pfizer Animal Health, Mt. Eden, Auckland,
New Zealand) on designated day 0 during the breeding
season (February). On day 12, CIDRs were removed and
500 IU of PMSG (Folligon®; Intervet Canada Ltd.,
Whitby, ON, Canada) were administered intramuscu-
larly. On the morning of day 19, food and water were
withdrawn in preparation for transcervical embryo
transfer (TCET). At this time, eleven ewes were ran-
domly allocated to the 24-h Cervidil® treatment group
and respective controls. The Cervidil® inserts were
placed in the vagina using a plastic Veramix® sponge ap-
plicator, which was cleaned and disinfected before each
use. For the designated treatment ewes, a Cervidil® insert
was placed across the front end of a placebo sponge with
both the attached cords from the insert and the sponge
lying in the same direction. Both units were then pushed
half-way into the barrel of the applicator with the plun-
ger. The barrel was then gently inserted into the vagina
with the cords pointing caudally. The plunger was used
to push both the sponge and the Cervidil® insert out of
the end of the barrel securing the insert in the proximity
of the cervix and the applicator was removed. The cord
of the Cervidil® insert and the cord of the sponge were
tied together and remained visible outside of the vulva.
Figure 1 Materials and tools used during Cervidil® treatment
and transcervical embryo transfer (TCET) in ewes. (A) Cervidil®®
vaginal insert; (B) Manufactured vaginal plugs used to prevent
premature loss of Cervidil® inserts from the vaginal canal in ewes;
(C) An illuminated vaginal canal of the ewe with a plexiglass
vaginoscope inserted. Forceps are used to retract the tissue
surrounding the cervical os and the tip of a modified insemination
gun is inserted into the cervical opening.
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a Cervidil® insert in the same fashion as described above.
The remaining 11 animals were allocated to the 12-h
Cervidil® exposure group and respective controls.
TCET was performed by a veterinarian experienced
in the Guelph system transcervical artificial insemina-
tion who remained unaware of which ewes had been
assigned to each group. Straws containing the embryoswere thawed in a 38°C water bath. Once thawed, embryo
quality was assessed via microscopy by an experienced
technician and those that were of acceptable quality
post-thawing were transferred to a culture dish contain-
ing a commercially available holding media (ViGro®
Holding Plus, Bioniche Animal Health, Belleville, ON,
Canada). The embryos were packaged with holding
media into 0.5-cc semen straws and kept in an incubator
at 38°C. Only Grade 1 embryos were used for transfer
in the present trial. TCET was performed on the ewes
in the same sequence as that used for the CIDR remov-
al and the insertion of Cervidil® inserts and sponge
plugs such that consistency in the time from Cervidil®
insertion to the start of TCET for the groups of the
12- and 24-h exposure designations was maintained.
A single straw containing 3 blastocysts was loaded into
the modified Cassou insemination gun used for the
Guelph system TCAI [1] and ewes were immobilized
in the Polvendale Commodore hoof trimming cradle
(Polvendale Equipment, London, England). Each ewe
was positioned and secured in a dorsal recumbency with
the hindquarters elevated at 30° to 40°; this positioning
has been shown to produce the least amount of stress
and also aids in elongating the cervix, hence facilitating
cervical penetration. The Cervidil® insert and/or the
sponge were removed, a plexiglass vaginoscope (tubular
speculum) covered with water-soluble lubricant was
inserted into the vagina, and a penlight was used to
visualize the cervical os and associated vaginal folds. The
tissue surrounding the cervical os was grasped with
26-cm Bozeman forceps and then gently retracted
approximately 5 to 10 cm using the forceps until taut
(Figure 1C). Once the os was clearly visible, the pre-
loaded insemination gun was introduced into the vagina
through the speculum and the tip of the pipette was
placed in the os. The gun was then rotated slightly, ad-
vancing the pipette carefully through each cervical ring.
It became evident that the entire cervix had been tra-
versed and the pipette tip had entered the body of the
uterus when resistance to the gentle pressure required
to advance the pipette forward was no longer felt. The
plunger of the gun was then depressed expelling the en-
tire content of a straw directly into the uterus close to
the bifurcation. Cervical manipulation with the insemin-
ation pipette was only attempted for a maximum of
3 min because if complete penetration was not achieved
at this point in time, any further cervical manipulation
may have led to injury. Embryos were not expelled if the
pipette tip could not be advanced into the uterus in
order to avoid pathologic pregnancy. Immediately after
this procedure, a straw and a tip of the insemination gun
were thoroughly rinsed with the holding media and the
fluid was examined under the microscope to ascertain
that all embryos were deposited in the uterus.
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Jugular blood samples were drawn on days 19, 20 (24 and
12 h before and just prior to TCET), 29 and 30. Blood col-
lected from all ewes into 10-ml Becton Dickinson red-top
vacutainers (Franklin Lakes, NJ, USA) was kept at room
temperature for approximately 24 h in order to promote
clotting prior to centrifugation at 1,500 × g for 10 min.
Serum was then harvested and stored at −20°C for radio-
immunoassay (RIA) analysis at a later date. All sam-
ples were analyzed for concentrations of estradiol 17-β
(E2) and progesterone (P4) by validated RIAs [12]. The
sensitivities of assays were 1.0 pg/ml and 0.03 ng/ml,
for E2 and P4 assays, respectively. The range of stan-
dards was from 1.0 to 50 pg/ml and from 10 pg/ml to
10 ng/ml, in the E2 and P4 RIAs, respectively. The
intra-assay coefficients of variation (CVs) for reference
sera with mean E2 concentrations of 5.6 or 11.5 pg/ml
were 7.1% and 13.7%, respectively. The intra-assay CVs
for reference sera with mean P4 concentrations of
1.32, 6.44 or 9.54 ng/ml were 8.4%, 2.9% and 0.8%,
respectively.
Ultrasonographic pregnancy detection
Twenty-five days post-TCET, all ewes were subjected to
transrectal ultrasonographic imaging with an Aloka 900
SSD portable ultrasound system (Hitachi Aloka Medical
Ltd., Tokyo, Japan) and a rigid 7.5-MHz transrectal
transducer. Pregnancy detection was repeated at 55 days
post-TCET using a 3.5-MHz transabdominal transducer
connected to the B-mode ultrasound scanner (HS-2000;
Honda Electronics Ltd., Toyohashi, Japan).
Data analyses
The statistical tools used to analyze the results included
χ2 tests (Brandt and Snedecor formula) for the analysis
of proportions; Student t-test and one-way analysis of
variance (ANOVA) for comparison of single-time point
variables between two or multiple groups, respectively;
two-way ANOVA (general linear model) for assessment
of repeated measurements and Pearson Product Mo-
ment correlations; all using the SigmaStat® statistical
analysis software package (Systat Software Inc.; Chicago,
IL, USA). Ewe-related parameters that were considered
of importance for this study were: the age on the day of
TCET, expressed in number of days; the body weight at
the start of the study period; the breed, defined as the
percentage of Rideau Arcott in the crossbred Rideau
Arcott x Polled Dorset genotype; the total number of
pregnancies over the lifetime prior to start of the study
period (i.e., ewe parity); the total number of lambs pro-
duced and delivered vaginally over the lifetime (referred
to as lifetime lamb production), and the time elapsed be-
tween the last lambing date and the date of TCET (the
post-partum interval).The “penetrated ewes” referred to successful embryo
transfers involving complete cervical penetration and
intrauterine embryo deposition while “non-penetrated
ewes” described unsuccessful transfers consisting of in-
complete or a lack of cervical penetration with no em-
bryo deposition. Three main variables were assessed:
i. the “cervical penetrability”, defined as the proportion/
percentage of ewes in which the entire cervix could be
traversed using the inseminating pipette and culminating
in uterine embryo deposition; ii. the total time taken, in
seconds, to complete the procedure, from the initial in-
sertion of the pipette to the deposition of embryos (pen-
etrated ewes) or pipette withdrawal (non-penetrated
ewes), referred to hereafter as “TT”; and iii. the time of
the final attempt, in seconds, or the time from the final
insertion of the pipette to embryo deposition in cases
where repeated repositioning of the pipette within the
reproductive tract of a ewe was necessary (referred to as
“FT”). Statistical significance was defined as p < 0.05 and
all results were expressed as mean ± SEM.
Results
In terms of overall cervical penetrability, 32% (7/22) of
ewes were successfully penetrated. Of those that were
penetrated, 86% (6/7) had been treated with Cervidil®
and 14% (1/7) was an untreated control. Within non-
penetrated ewes, only 33% (5/15) had been treated
whereas 67% (10/15) had not received treatment. Of the
non-penetrated ewes primed with Cervidil®, 60% (3/5)
had a 12-h Cervidil® treatment and 40% (2/5) a 24-h ex-
posure. Within the treated ewes that had been pene-
trated, 67% (4/6) had been exposed to Cervidil® for 24 h
and the remaining ewes had had a 12-h exposure. When
comparing the treatment and control groups overall, the
proportion of successfully penetrated ewes (55%, 6/11)
was significantly greater in the Cervidil®-treated animals
compared with controls (9%, 1/11). Within this subset of
ewes, the 24-h treatment group exhibited significantly
greater cervical penetration rate than respective controls,
but the difference between 12-h treatment group and
corresponding controls was not significant (Table 2).
Serum E2 concentrations and E2 : P4 ratios declined
(p < 0.05) from 24 h before to the time of TCET in both
the 12-h Cervidil®-treated ewes and their respective con-
trols (Table 2). A significant rise in circulating P4 con-
centrations occurred over the 24 h before TCET in the
24-h treated ewes and between 24 and 12 h prior to
TCET in the 12-h control group (Table 2).
The variation in the age, weight, breed, parity, lifetime
lamb production and post-partum interval among the
penetrated and non-penetrated ewes in this experiment
was not significant (p > 0.05, Table 3). Similarly, serum
P4 and E2 concentrations and E2 : P4 ratios at 24 and
12 h prior to TCET and at the time of TCET did not
Table 2 The cervical penetrability, total time taken to
perform the procedure (TT), time of the final attempt (FT)
and estradiol/progesterone (E2 : P4) concentrations/ratios
for the Cervidil®-treated cyclic Rideau Arcott x Polled










Cervical penetrability 2/5 (40%) 4/6 (67%)* 1/6 (16%) 0/5 (0%)*
TT (sec) 168 ± 22 110 ± 29 170 ± 28 180 ± 26
FT (sec) 38 ± 23 27 ± 5 154 -
E2 – 24 h prior (pg/ml) 2.4 ± 0.4† 1.8 ± 0.4 2.9 ± 0.4† 1.5 ± 0.2
E2 – 12 h prior (pg/ml) 1.9 ± 0.3 1.7 ± 0.4 2.6 ± 0.5 1.6 ± 0.5
E2 – TCET (pg/ml) 1.7 ± 0.3† 1.7 ± 0.4 1.9 ± 0.5† 1.2 ± 0.2
P4 – 24 h prior (ng/ml) 3.4 ± 0.6 2.6 ± 0.4§ 2.7 ± 0.3§‡ 2.9 ± 0.6
P4 – 12 h prior (ng/ml) 3.8 ± 0.4 4.0 ± 0.7 3.5 ± 0.5§ 3.4 ± 0.6
P4 – TCET (ng/ml) 4.1 ± 0.5 3.8 ± 0.6§ 3.7 ± 0.6‡ 3.6 ± 0.4
E2 : P4 – 24 h prior 0.9 ± 0.3‡ 0.8 ± 0.3 0.9 ± 0.2• 0.6 ± 0.1
E2 : P4 – 12 h prior 0.5 ± 0.1 0.5 ± 0.07 0.8 ± 0.3 0.6 ± 0.3
E2 : P4 – TCET 0.4 ± 0.08‡ 0.5 ± 0.2 0.6 ± 0.2• 0.4 ± 0.07
Due to low numbers of penetrated control ewes, there are no comparisons of
FT between the treatment and control groups.
A significant difference (p < 0.05) exists between the two values denoted by
the same symbols: *within rows; †§‡• within columns.
Table 3 A comparison of ewe-related parameters, and estradi
transcervical embryo transfer (TCET) and at the time of TCET
Arcott x Polled Dorset ewes
Variable/Group Penetrated (n = 7)
Treatment (n = 6) Control (
12-h (n = 2) 24-h (n = 4) 12-h (n = 1)
Age (days) 1524 ± 155
Weight (kg) 80.6 ± 3.1
Breed (% Rideau Arcott) 58.1 ± 8.7
Parity 2.3 ± 0.5
Lifetime lamb production 5.0 ± 1.2
Post-partum interval (d) 261 ± 20
E2 – 24 h prior (pg/ml) 2.0 ± 0.4
E2 – 12 h prior (pg/ml) 1.6 ± 0.2
E2 – TCET (pg/ml) 1.6 ± 0.3
P4 – 24 h prior (ng/ml) 2.8 ± 0.4§
P4 – 12 h prior (ng/ml) 3.3 ± 0.4
P4 – TCET (ng/ml) 3.8 ± 0.5§
E2 : P4 – 24 h prior 0.9 ± 0.3†
E2 : P4 – 12 h prior 0.6 ± 0.1
E2 : P4 – TCET 0.5 ± 0.09†
Within columns, a significant difference (p < 0.05) exists between the two values de
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Table 3). Serum E2 concentrations and E2 : P4 ratio declined
(p < 0.05) from 24 h before to just prior to TCET, whereas
P4 levels increased from 24 to 12 h before TCET in non-
penetrated ewes (Table 3). In the successfully penetrated
ewes, serum concentrations of P4 increased and values for
E2 : P4 ratio declined from 24 h before to the time of TCET
(p < 0.05, Table 3).
The total time (TT) required to perform the procedure
and recorded in all ewes or in the penetrated animals
only was not correlated with the ewe-related and endo-
crine parameters or with the VMI values determined in
the present experiment (p > 0.05, Table 4). However, the
duration of the final attempt (FT) preceding successful
cervical penetration and uterine deposition of embryos
was negatively correlated (p ≤ 0.05) with the ewes’ age,
parity, lifetime lamb productivity and the duration of the
post-partum interval (Table 4).
Serum P4 concentrations on days 29 and 30 of the
experiment (9 and 10 days post-TCET, respectively)
declined to basal levels in all but two animals. Ultra-
sonographic pregnancy detection performed 25 days
post-TCET confirmed that the two ewes (one from the
12-h and one from the 24-h treatment group) were preg-
nant; however, a subsequent ultrasonographic scan on
day 55 post-TCET revealed that these pregnancies had
not been sustained.ol/progesterone concentrations/ratios (at 24 h prior to
) between the penetrated and non-penetrated Rideau
Non-penetrated (n = 15)
n = 1) Treatment (n = 5) Control (n = 10)
















noted by the same symbols: †§‡•.
Table 4 Summary of correlations between the ewe-related characteristics and estradiol/progesterone concentrations/
ratios at 24 h prior to transcervical embryo transfer (TCET) and at the time of TCET with the total time taken to
perform the procedure (TT) and the time of the final attempt (FT) (the latter for penetrated ewes only) determined in
22 Rideau Arcott x Polled Dorset ewes
Variable/Outcomes Total time (sec) Total time (sec) Time of the last attempt (sec)
(All ewes, n = 22) (Penetrated ewes only, n = 7) (Penetrated ewes only, n = 7)
Age (days) r = −0.26, p = 0.25 r = −0.21, p = 0.29 r = −0.59, p < 0.05
Weight (kg) r = 0.0007, p = 0.98 r = 0.01, p = 0.96 r = 0.02, p = 0.95
Breed (% Rideau Arcott) r = −0.16, p = 0.49 r = −0.02, p = 0.93 r = −0.11, p = 0.71
Parity r = −0.12, p = 0.56 r = −0.12, p = 0.56 r = −0.52, p = 0.05
Lifetime lamb production r = −0.07, p = 0.76 r = 0.05, p = 0.81 r = −0.59, p < 0.05
Post-partum interval (days) r = −0.27, p = 0.23 r = −0.35, p = 0.08 r = −0.60, p < 0.05
E2 – 24 h prior (pg/ml) r = −0.31, p = 0.18 r = −0.22, p = 0.29 r = −0.31, p = 0.28
E2 – 12 h prior (pg/ml) r = −0.03, p = 0.90 r = −0.07, p = 0.72 r = −0.36, p = 0.20
E2 – TCET (pg/ml) r = 0.08, p = 0.72 r = 0.02, p = 0.93 r = −0.16, p = 0.59
P4 – 24 h prior (ng/ml) r = −0.16, p = 0.51 r = −0.22, p = 0.30 r = 0.19, p = 0.51
P4 – 12 h prior (ng/ml) r = −0.15, p = 0.51 r = −0.15, p = 0.45 r = 0.44, p = 0.11
P4 – TCET (ng/ml) r = −0.31, p = 0.16 r = −0.34, p = 0.08 r = 0.22, p = 0.45
E2 : P4 – 24 h prior r = −0.12, p = 0.61 r = −0.04, p = 0.84 r = −0.39, p = 0.16
E2 : P4 – 12 h prior r = 0.06, p = 0.79 r = 0.04, p = 0.84 r = −0.52, p = 0.06
E2 : P4 – TCET r = 0.22, p = 0.31 r = 0.21, p = 0.29 r = −0.40, p = 0.15
Significant correlations are indicated by the bold font and correlations approaching to significance (p < 0.10) are italicized. r - coefficient of correlation.
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The extremely low proportion of control ewes success-
fully penetrated during the present TCET trial indicates
that the ovine cervix is highly constricted in the luteal
phase of the estrous cycle. The application of Cervidil®
has been met with a sizeable dilation of the cervix, espe-
cially after the 24-h exposure. The average total time
taken to penetrate the cervix was 1–2 min and this is
within the range of TT observed in Cervidil®-treated
ewes from the transcervical artificial insemination
(TCAI) trials in the breeding (unpublished results) and
non-breeding seasons [13].
Kershaw-Young et al. [14] have shown that PgE2 medi-
ates its effects on the cervix through four receptors, EP1
through EP4; EP2 and EP4 especially have been found to
be involved in cervical dilation. EP2 and EP4 mRNA is
expressed in the sheep cervix throughout the estrous
cycle. In fact, Kershaw-Young et al. [14] revealed that a
gradient of EP2 and EP4 mRNA expression existed along
the cervix such that the greatest expression was found in
the vaginal and mid-cervical region and the lowest in
the uterine region. This indicates that the vaginal region
may actually be more responsive to the effects of PgE2,
and considering that dilation of merely the first two cau-
dal folds is thought to produce sufficient cervical dila-
tion for the purpose of TCAI/ET, the local application of
Cervidil® may be beneficial. Although the EP2 mRNA
has been shown to be highest prior to the LH surge, theEP4 mRNA expression remains constant over the estrous
cycle. The direct binding of locally applied PgE2 to con-
stitutively expressed receptors may lead to PgE2-induced
cervical dilation during diestrus.
Cervical dilation prior to parturition is initially in-
duced by a decline in progesterone with a concomitant
increase in estradiol [1]. However, the notion that ster-
oid hormone milieu may influence the effect of Cervidil®
on the dilation of ovine cervix in diestrous ewes was not
supported in this study. Serum concentrations of E2, P4
and E2 : P4 ratios generally did not vary between pene-
trated and non-penetrated ewes, and negative correla-
tions between TT and P4 levels at TCET and between
FT and E2 : P4 ratios at 12 h before TCET in successfully
penetrated ewes only approached to significance.
Windsor et al. [15] found a significant effect of ewe
parity on cervical penetration rates in synchronized ewes
during seasonal anestrus but not in normally cycling,
non-synchronized ewes in the breeding season. Some
studies have reported a correlation between the breed
and cervical penetrability [16], which may be due to the
morphological differences in cervical structure between
various genotypes of ewes; in general, the breeds with
higher cervical complexity exhibited a lower degree of
cervical penetration. There was an apparent effect of
breed (specifically, the % of Rideau Arcott genotype) on
the penetration rates in the present diestrous ewes.
Kaabi et al. [16] also described a significant correlation
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within a similar age range to that in the present study;
however, this may be confounded by factors such as par-
ity. Significant negative correlations between FT and the
ewes’ age, parity and lifetime lamb production were
found in this study. Buckrell et al. [17] suggested that
penetration success in the ewes undergoing TCAI was
affected by the post-partum interval; a shorter interval
was shown to significantly increase penetration rate.
However, Windsor et al. [15] reported that cervical
penetration rate was not affected by an increase in post-
partum interval at TCAI, from 12 to 26 wks after lamb-
ing. The results from the present study have indicated
that the duration of the post-partum interval from 225
to 1001 days (32 to 143 wks) was inversely related to the
ease of cervical penetration or the time taken to traverse
the cervix and deposit embryos.
The ultimate testament to the success of Cervidil®-
facilitated TCET would be corroboration with sound
fertility data comparable to laparoscopic ET or natural
mating. In the ewes of the present study, serum P4 mea-
surements and ultrasonographic imaging enabled the
detection of two pregnancies, which were not subse-
quently maintained until day 55 post-TCET. There are
many factors that may have contributed to the low fertil-
ity observed in this experiment. The transfer of frozen-
thawed ovine embryos is usually associated with lower
pregnancy rates compared with the transfer of freshly
obtained embryos [3]. An additional factor that may
have contributed to low fertility could have been em-
bryo handling. Considering that the straw containing
embryos is loaded into the insemination gun before
cervical penetration is attempted, there is a consider-
able amount of time in which the embryos are exposed
to external environment before they are deposited. Min-
imizing this exposure time would be beneficial since
embryonic cells can be very sensitive to even minor fluc-
tuations in temperature or air pressure or to possible
contact with pathogens.
Sayre and Lewis [18], and Campbell et al. [19] have
suggested that the transcervical method itself may have
detrimental effects on fertility. Mechanical stimulation
during manipulation of the cervix may damage the epi-
thelial lining and result in the activation of sensitive
areas triggering the release of various inflammatory me-
diators that affect uterine tone and create inhospitable
environment for embryos [5,20]; such molecules may
have direct embryocidal effects.
It is unlikely that dinoprostone, Cervidil® inserts and/
or cervical plugs had a direct detrimental effect on fertil-
ity after TCET. Mammalian embryos secrete large quan-
tities of PgE2 to facilitate their entry into the uterus and
PgE2 also has a significant involvement in embryo im-
plantation [21]. It was shown that estradiol upregulatesPgE2 production by the endometrium in sheep and in-
hibition of PgE2 synthesis prevents implantation, which
can be restored by the administration of endogenous
PgE2 [22].
Conclusions
In closing, the impenetrability of the ovine cervix using
conventional instruments is a major factor precluding
the widespread use of TCET in sheep. Pharmacological
dilation of the cervix can significantly improve the ease
with which the ovine cervix can be penetrated. Cervidil®,
a dinoprostone-containing vaginal insert with a slow
release mechanism currently used to induce labor in
women, can improve cervical penetration rates for the
novel method of TCET.
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